We are live on !
Find out more
ACPLP
ACT Capital Partners, L.P. Portfolio holdings
AUM
$154M
This Fund
S&P 500
This Quarter Est. Return
-1.02%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
–
Cap. Flow
+$157M
Cap. Flow % of AUM
Cap. Flow %
101.65%
Top 10 Holdings %
Top 10 Hldgs %
64.62%
Holding
58
New
58
Increased
–
Reduced
–
Closed
–
Avg Time Held
Equity + Options
0
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0
years
Avg Time Held Equity only
0
years
Top 10 Avg Time Held Equity only
0
years
Top 20 Avg Time Held Equity only
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$14.8M |
| 2 |
Krystal Biotech
KRYS
|
+$14.5M |
| 3 |
TG Therapeutics
TGTX
|
+$12.8M |
| 4 |
ExxonMobil
XOM
|
+$12.3M |
| 5 |
Amazon
AMZN
|
+$10.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.89% |
| 2 | Energy | 21.53% |
| 3 | Technology | 12.48% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Miscellaneous | 2.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Ambarella
AMBA
$2.58B
| $1.21M | 0.79% |
+17,400
| New | +$1.26M |
2026 Q3
0 quarters
|
|
27
Applied Optoelectronics
AAOI
$4.26B
| $1.19M | 0.77% |
+12,000
| New | +$1.35M |
2026 Q3
0 quarters
|
|
28
CALL
Tesla
TSLA
$1.42T
| $1.06M | 0.69% |
+3,000
| New | +$1.07M |
2026 Q3
0 quarters
|
|
29
Grayscale Bitcoin Trust
GBTC
$11.3B
| $995K | 0.65% |
+15,400
| New | +$848K |
2026 Q3
0 quarters
|
|
30
Kura Oncology
KURA
$647M
| $981K | 0.64% |
+91,600
| New | +$1.02M |
2026 Q3
0 quarters
|
|
31
Sagimet Biosciences
SGMT
$698M
| $593K | 0.39% |
+60,000
| New | +$551K |
2026 Q3
0 quarters
|
|
32
Compass Pathways
CMPS
$1.22B
| $567K | 0.37% |
+45,600
| New | +$606K |
2026 Q3
0 quarters
|
|
33
Vir Biotechnology
VIR
$2.07B
| $559K | 0.36% |
+50,000
| New | +$500K |
2026 Q3
0 quarters
|
|
34
ON Semiconductor
ON
$24.6B
| $553K | 0.36% |
+7,200
| New | +$578K |
2026 Q3
0 quarters
|
|
35
Alpha Cognition
ACOG
$181M
| $464K | 0.3% |
+51,500
| New | +$450K |
2026 Q3
0 quarters
|
|
36
Cerebras Systems
CBRS
$21.3B
| $444K | 0.29% |
+2,500
| New | +$503K |
2026 Q3
0 quarters
|
|
37
Adlai Nortye Group ADS
ANL
$662M
| $430K | 0.28% |
+24,400
| New | +$328K |
2026 Q3
0 quarters
|
|
38
Palisade Bio
PALI
$197M
| $415K | 0.27% |
+307,500
| New | +$600K |
2026 Q3
0 quarters
|
|
39
Regenxbio
RGNX
$503M
| $395K | 0.26% |
+52,500
| New | +$533K |
2026 Q3
0 quarters
|
|
40
Nokia
NOK
$42.9B
| $355K | 0.23% |
+35,000
| New | +$364K |
2026 Q3
0 quarters
|
|
41
UiPath
PATH
$6.78B
| $347K | 0.23% |
+27,000
| New | +$375K |
2026 Q3
0 quarters
|
|
42
Kazia Therapeutics
KZIA
$112M
| $336K | 0.22% |
+35,000
| New | +$439K |
2026 Q3
0 quarters
|
|
43
Corvus Pharmaceuticals
CRVS
$887M
| $311K | 0.2% |
+27,000
| New | +$376K |
2026 Q3
0 quarters
|
|
44
Arcturus Therapeutics
ARCT
$294M
| $308K | 0.2% |
+22,500
| New | +$235K |
2026 Q3
0 quarters
|
|
45
Ondas Inc
ONDS
$3.1B
| $275K | 0.18% |
+37,500
| New | +$295K |
2026 Q3
0 quarters
|
|
46
Kyverna Therapeutics
KYTX
$302M
| $272K | 0.18% |
+40,000
| New | +$316K |
2026 Q3
0 quarters
|
|
47
Keel Infrastructure Corp
KEEL
$1.15B
| $263K | 0.17% |
+74,500
| New | +$286K |
2026 Q3
0 quarters
|
|
|
CCXI
48
DELISTED
Churchill Capital Corp XI
CCXI
| $261K | 0.17% |
+22,500
| New | +$324K |
2026 Q3
0 quarters
|
|
49
ARKO Petroleum
APC
$704M
| $223K | 0.14% |
+15,000
| New | +$284K |
2026 Q3
0 quarters
|
|
50
X-Energy Inc
XE
$3B
| $177K | 0.12% |
+12,500
| New | +$215K |
2026 Q3
0 quarters
|
|
Similar funds
MWM
GFG
OP
ACT Capital Partners, L.P.'s Q3 2026 Portfolio in Review
Q3 2026 is the first quarter with a 13F filing on record for ACT Capital Partners, L.P., which disclosed 58 positions worth $154M. Its ten largest holdings account for 65% of the portfolio.
Its largest position is Chevron: 75,000 shares worth $15.3M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, followed by Energy and Technology.
- ACT Capital Partners, L.P.'s largest Q3 2026 buy was Chevron: 75,000 shares worth $15.3M.
- ACT Capital Partners, L.P.'s ten largest holdings make up 65% of its $154M portfolio in Q3 2026.
- ACT Capital Partners, L.P. disclosed 58 positions in Q3 2026, its first 13F filing on record.
Based on ACT Capital Partners, L.P.'s 13F filing for Q3 2026, filed 6 Nov 2026.